Variant report
Variant | nsv528532 |
---|---|
Chromosome Location | chr9:12907902-12910295 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13293601 | chr9:12907902-12907903 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs16929881 | chr9:12907929-12907930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576027666 | chr9:12907936-12907937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs16929883 | chr9:12907969-12907970 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs539313760 | chr9:12907970-12907971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150816086 | chr9:12907972-12907973 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs373300818 | chr9:12908028-12908029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571939241 | chr9:12908055-12908056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540707645 | chr9:12908056-12908057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560424038 | chr9:12908088-12908089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10960830 | chr9:12908106-12908107 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs10756423 | chr9:12908130-12908131 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs139266542 | chr9:12908158-12908159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149998107 | chr9:12908202-12908203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10738298 | chr9:12908215-12908216 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs114273177 | chr9:12908219-12908220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534162406 | chr9:12908225-12908226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs377230611 | chr9:12908236-12908237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs116541690 | chr9:12908237-12908238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570500244 | chr9:12908238-12908239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539377939 | chr9:12908259-12908260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555532795 | chr9:12908292-12908293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555902562 | chr9:12908293-12908294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575904576 | chr9:12908298-12908299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10809858 | chr9:12908303-12908304 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs540841130 | chr9:12908313-12908314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10738299 | chr9:12908314-12908315 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs377335403 | chr9:12908353-12908354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10756424 | chr9:12908447-12908448 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs374703272 | chr9:12908457-12908458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74681900 | chr9:12908460-12908461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369318925 | chr9:12908492-12908493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554194767 | chr9:12908496-12908497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147695244 | chr9:12908569-12908570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187558610 | chr9:12908582-12908583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192803972 | chr9:12908590-12908591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562889943 | chr9:12908606-12908607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183814036 | chr9:12908681-12908682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548642599 | chr9:12908706-12908707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10960831 | chr9:12908711-12908712 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs187830267 | chr9:12908724-12908725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142474536 | chr9:12908726-12908727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs77340745 | chr9:12908744-12908745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs10960832 | chr9:12908784-12908785 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs568237573 | chr9:12908816-12908817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs527745131 | chr9:12908839-12908840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112747056 | chr9:12908863-12908864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569295492 | chr9:12908869-12908870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs146653075 | chr9:12908870-12908871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372144087 | chr9:12908871-12908872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:12905000-12915600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr9:12907200-12908000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr9:12909000-12909400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |